Azala

In silico phytochemicals analysis as inhibitors of the SARS-COV-2 main protease

<p>Background: The world population's full immunization with vaccines against SARS-CoV-2 is still challenging. Therefore, more research must be needed to find an active antiviral drug against the virus, including new mutated strains.</p><p>Results: Therefore, this research ana...

Deskribapen osoa

Gorde:

Xehetasun bibliografikoak
Egile Nagusiak:	Ekaterina Serikova (Egilea), Victor Gustavo Oliveira Evangelho (Egilea), Marianna Kremenevskaya (Egilea), Camila Ferreira Mattos (Egilea), Juliana Silva Novais (Egilea), Marcos Vinicius Santana (Egilea), Carlos Rangel Rodrigues (Egilea), Reinaldo Barros Geraldo (Egilea), Helena Carla Castro (Egilea)
Formatua:	Liburua
Argitaratua:	International Journal of Pharmaceutical Sciences and Developmental Research - Peertechz Publications, 2022-08-29.
Gaiak:	Research Article
Sarrera elektronikoa:	Connect to this object online.
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak

In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2
nork: Baby Krishnaprasad, et al.
Argitaratua: (2020)

Docking and Dynamics Study of Phytochemicals as Potent Inhibitors against SARS-CoV-2 Main Protease
nork: Palla Ramprasad, et al.
Argitaratua: (2022)

In-Silico Screening of Mitragynine Derivates from the Genus Mitragyna Korth Targeting the Main Protease of the SARS-COV-2
nork: Islamudin Ahmad, et al.
Argitaratua: (2023)

Phytoconstituents from ten natural herbs as potent inhibitors of main protease enzyme of SARS-COV-2: In silico study
nork: Nitish Kumar, et al.
Argitaratua: (2021)

Activity Prediction of Bioactive Compounds Contained in Etlingera elatior Against the SARS-CoV-2 Main Protease: An In Silico Approach
nork: Dwi Syah Fitra Ramadhan, et al.
Argitaratua: (2020)

SARS-CoV-2 spike protein-, main protease- and papain-like-protease-targeting peptides from seed proteins following gastrointestinal digestion: An in silico study
nork: Fai-Chu Wong, et al.
Argitaratua: (2021)

In silico investigation of HCV and RNA synthesis inhibitor antibiotic drugs as potential inhibitors of SARS‑CoV‑2 main protease (Mpro)
nork: Merusomayajula V. Kishore, et al.
Argitaratua: (2024)

Chlorhexidine and SARS-CoV-2 main protease: Molecular docking study
nork: Vishakha Grover, et al.
Argitaratua: (2022)

In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing
nork: Yogesh Kumar, et al.
Argitaratua: (2020)

Flavonoid compounds of buah merah (Pandanus conoideus Lamk) as a potent SARS-CoV-2 main protease inhibitor: in silico approach
nork: Abd. Kakhar Umar
Argitaratua: (2021)

In Silico Prediction of Novel Inhibitors of SARS-CoV-2 Main Protease through Structure-Based Virtual Screening and Molecular Dynamic Simulation
nork: Sobia Ahsan Halim, et al.
Argitaratua: (2021)

Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)
nork: Soumya Gulab Katre, et al.
Argitaratua: (2022)

Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents
nork: Mohammad Z. Ahmed, et al.
Argitaratua: (2021)

Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays
nork: Chunlong Ma, et al.
Argitaratua: (2022)

Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease
nork: Luca Pinzi, et al.
Argitaratua: (2021)

QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease
nork: Fucheng Song, et al.
Argitaratua: (2023)

New Thiazolidine-4-One Derivatives as SARS-CoV-2 Main Protease Inhibitors
nork: Antonella Messore, et al.
Argitaratua: (2024)

Investigation of phytochemicals isolated from selected Saudi medicinal plants as natural inhibitors of SARS CoV-2 main protease: In vitro, molecular docking and simulation analysis
nork: Yousef T.M. Alharbi, et al.
Argitaratua: (2024)

Potency, Safety, and Pharmacokinetic Profiles of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
nork: Hylemariam Mihiretie Mengist, et al.
Argitaratua: (2021)

Computational approach towards the design of artemisinin-thymoquinone hybrids against main protease of SARS-COV-2
nork: Victor Moreira de Oliveira, et al.
Argitaratua: (2021)

Assessment of Antioxidant, Immunomodulatory Activity of Oxidised Epigallocatechin-3-Gallate (Green Tea Polyphenol) and Its Action on the Main Protease of SARS-CoV-2-An In Vitro and In Silico Approach
nork: Ramakrishna Ungarala, et al.
Argitaratua: (2022)

In-silico study MM/GBSA binding free energy and molecular dynamics simulation of some designed remdesivir derivatives as the inhibitory potential of SARS-CoV-2 main protease
nork: Maryam Abbasi, et al.
Argitaratua: (2024)

Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking
nork: Xinbo Yang, et al.
Argitaratua: (2022)

Molecular Docking of Novel 5-O-benzoylpinostrobin Derivatives as SARS-CoV-2 Main Protease Inhibitors
nork: Mohammad Rizki Fadhil Pratama, et al.
Argitaratua: (2020)

Development of an active-site titrant for SARS-CoV-2 main protease as an indispensable tool for evaluating enzyme kinetics
nork: Rabea Voget, et al.
Argitaratua: (2024)

The Possible Molecular Mechanism of SARS-CoV-2 Main Protease: New Structural Insights from Computational Methods
nork: Alvea Tasneem, et al.
Argitaratua: (2021)

Prediction of Asiatic Acid Derivatives Affinity Against SARS-CoV-2 Main Protease Using Molecular Docking
nork: Ida Musfiroh, et al.
Argitaratua: (2020)

Identification of SARS-CoV-2 Main Protease Inhibitors Using Chemical Similarity Analysis Combined with Machine Learning
nork: Karina Eurídice Juárez-Mercado, et al.
Argitaratua: (2024)

Insights for Future Pharmacology: Exploring Phytochemicals as Potential Inhibitors Targeting SARS-CoV-2 Papain-like Protease
nork: Jawaria Jabeen, et al.
Argitaratua: (2024)

Virtual Screening for SARS-CoV-2 Main Protease Inhibitory Peptides from the Putative Hydrolyzed Peptidome of Rice Bran
nork: Nathaphat Harnkit, et al.
Argitaratua: (2022)

Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Targets for Broad-Spectrum Anti-Coronavirus Agents
nork: Alzyoud L, et al.
Argitaratua: (2022)

Identification of highly effective inhibitors against SARS-CoV-2 main protease: From virtual screening to in vitro study
nork: Hu Wang, et al.
Argitaratua: (2022)

Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery
nork: Maria Yu. Zakharova, et al.
Argitaratua: (2021)

Autochthonous Peruvian Natural Plants as Potential SARS-CoV-2 M<sup>pro</sup> Main Protease Inhibitors
nork: Maria Nuria Peralta-Moreno, et al.
Argitaratua: (2023)

Identification of Potential Flavonoid Inhibitors of the SARS-CoV-2 Main Protease 6YNQ: A Molecular Docking Study
nork: Sumit Arora, et al.
Argitaratua: (2020)

In Silico Studies on The Potential of Green Tea Catechin Compounds (Camellia sinensis) as Antiviral of SARS CoV-2 Againts Spike Glycoprotein (6LZG) and Main Protease (5R7Y)
nork: Futna Naufa, et al.
Argitaratua: (2022)

Molecular docking and dynamic simulations study for repurposing of multitarget coumarins against SARS-CoV-2 main protease, papain-like protease and RNA-dependent RNA polymerase
nork: Mai E. Shoman, et al.
Argitaratua: (2022)

Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332
nork: Matteo Pavan, et al.
Argitaratua: (2021)

Identification of sulphonamide-tethered N-((triazol-4-yl)methyl)isatin derivatives as inhibitors of SARS-CoV-2 main protease
nork: Mai H. ElNaggar, et al.
Argitaratua: (2023)

Development of potent and effective SARS-CoV-2 main protease inhibitors based on maleimide analogs for the potential treatment of COVID-19
nork: Karol Biernacki, et al.
Argitaratua: (2024)